Icosapent Ethyl
NDC 67184-0582, Icosapent Ethyl, capsule, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0582
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218899
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0582 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ICOSAPENT ETHYL1 g/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0582-1 | 67184058201 | 120 CAPSULE in 1 BOTTLE (67184-0582-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/20686acb-66c5-4d75-9684-7474436e8bef
Use it
Look up 67184-0582 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0582 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0582. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.